|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2005-05-04 Sale |
2005-05-05 3:15 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 10,909 | $9.6 | $104,726 | 27,319 (Direct) | View |
| 2004-12-14 Sale |
2004-12-16 3:48 pm | TEXAS GENCO HOLDINGS INC | TGN | CRUIKSHANK ROBERT J (Director) | 350 | $47 | $16,450 | 0 (Direct) |
View |
| 2004-02-19 Sale |
2004-02-20 7:34 pm |
KAISER ALUMINUM CORP | KLUCQ | CRUIKSHANK ROBERT J (Director) | 1,799 | $0 | $0 | 2,000 (Direct) |
View |
| 2003-12-29 Purchase |
2003-12-31 11:39 am | WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 19 | $44.96 | $873 | 3,019 (Direct) |
View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount | Shares Ownership |
Filing |
| 2008-05-12 Option Award Other |
2008-05-16 10:26 am | WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 2,477 | $35.15 | $87,075 | 12,788 (Direct) | View |
| 2008-04-01 Equity Swap | 2008-04-03 5:55 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 63,376 | $2.35 | $148,934 | 0 (Direct) | View |
| 2008-01-11 Option Award | 2008-01-15 5:17 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 12,323 | $0 | $0 | 63,376 (Direct) | View |
| 2007-10-12 Option Award | 2007-10-16 12:04 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 5,794 | $0 | $0 | 51,053 (Direct) |
View |
| 2007-08-23 Option Award | 2007-08-24 6:09 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 4,915 | $0 | $0 | 45,259 (Direct) |
View |
| 2007-05-03 Option Award Other | 2007-05-04 2:51 pm | WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 1,752 | $47.83 | $83,812 | 10,310 (Direct) |
View |
| 2007-04-02 Option Award |
2007-04-03 8:10 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 3,228 | $0 | $0 | 40,344 (Direct) |
View |
| 2007-01-09 Other |
2007-01-10 2:55 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 2,078 | $0 | $0 | 37,116 (Direct) |
View |
| 2006-10-02 Other |
2006-10-04 11:43 am |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 2,034 | $0 | $0 | 35,038 (Direct) |
View |
| 2006-06-15- -2006-08-30 Option Award Other | 2006-09-01 12:28 pm | WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 258 | $41.3 | $10,655 | 8,558 (Direct) |
View |
| 2006-07-10 Other |
2006-07-11 1:55 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 1,290 | $0 | $0 | 33,004 (Direct) | View |
| 2006-07-06 Other |
2006-07-06 1:48 pm | KAISER ALUMINUM CORP | KLUCQ.OB | CRUIKSHANK ROBERT J (Director) | 2,000 | $0 | $0 | 0 (Direct) | View |
| 2006-05-01 Option Award Other | 2006-05-03 1:44 pm |
WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 1,621 | $38.56 | $62,504 | 8,300 (Direct) | View |
| 2006-03-31 Other |
2006-04-04 4:39 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 1,753 | $0 | $0 | 31,714 (Direct) |
View |
| 2005-12-31 Other |
2006-01-04 11:35 am |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 1,108 | $0 | $0 | 29,961 (Direct) | View |
| 2005-09-30 Other | 2005-10-03 7:08 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 735 | $11.89 | $8,739 | 28,853 (Direct) | View |
| 2005-06-30 Other | 2005-07-01 12:34 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 799 | $10.95 | $8,749 | 28,118 (Direct) | View |
| 2005-05-05 Option Award | 2005-05-09 3:00 pm |
WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 1,400 | $36.4 | $50,960 | 6,679 (Direct) | View |
| 2005-05-04 Exercise |
2005-05-05 3:15 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 10,909 | $1.375 | $15,000 | 38,228 (Direct) |
View |
| 2005-03-31 Other |
2005-04-01 6:10 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 843 | $10.37 | $8,742 | 27,319 (Direct) |
View |
| 2005-01-10 Other | 2005-01-10 6:58 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 869 | $10.06 | $8,742 | 26,476 (Direct) |
View |
| 2004-10-08 Other | 2004-10-08 5:05 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 970 | $9.02 | $8,749 | 25,607 (Direct) |
View |
| 2004-07-16 Other | 2004-07-16 11:34 am | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 882 | $8.55 | $7,541 | 24,637 (Direct) | View |
| 2004-05-05 Exercise Tax Withholding | 2004-05-07 6:04 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 3,255 | $6.143 | $19,996 | 23,755 (Direct) |
View |
| 2004-04-28 Option Award | 2004-04-29 4:33 pm |
WEINGARTEN REALTY INVESTORS | WRI | CRUIKSHANK ROBERT J (Director) | 750 | $29.2 | $21,900 | 5,279 (Direct) |
View |
| 2004-04-16 Other |
2004-04-16 1:51 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 473 | $10.04 | $4,749 | 22,604 (Direct) | View |
| 2004-01-23 Other | 2004-01-23 11:35 am | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 488 | $8.7 | $4,246 | 22,131 (Direct) |
View |
| Transaction & Date | Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-06-10 Option Sale |
2008-06-10 5:18 pm |
N/A 2013-05-16 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 7,500 | $2.33 | 0 (Direct) |
View |
| 2008-05-30 Option Award | 2008-06-03 4:51 pm |
N/A 2018-05-30 | MAXXAM INC | MXM | CRUIKSHANK ROBERT J (Director) | 600 | $28.5 | 600 (Direct) | View |
| 2007-05-31 Option Award | 2007-06-04 12:24 pm |
N/A 2017-05-31 | MAXXAM INC | MXM | CRUIKSHANK ROBERT J (Director) | 600 | $29.25 | 600 (Direct) | View |
| 2007-05-09 Option Award |
2007-05-10 5:41 pm | N/A 2017-05-09 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 7,500 | $3.44 | 7,500 (Direct) | View |
| 2006-05-25 Option Award | 2006-05-26 12:37 pm | N/A 2016-05-25 |
MAXXAM INC | MXM | CRUIKSHANK ROBERT J (Director) | 600 | $31.69 | 600 (Direct) |
View |
| 2006-05-12 Option Award | 2006-05-16 2:57 pm |
N/A 2016-05-12 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 7,500 | $3.57 | 7,500 (Direct) | View |
| 2005-05-26 Option Award |
2005-05-27 3:10 pm | N/A 2015-05-26 |
MAXXAM INC | MXM | CRUIKSHANK ROBERT J (Director) | 600 | $22.58 | 600 (Direct) |
View |
| 2005-05-11 Option Award | 2005-05-13 5:10 pm | N/A 2015-05-11 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 7,500 | $9.76 | 7,500 (Direct) | View |
| 2005-05-04 Exercise | 2005-05-05 3:15 pm | N/A 2005-05-19 | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 10,909 | $1.375 | 0 (Direct) | View |
| 2004-05-20 Option Award | 2004-05-21 4:02 pm |
N/A 2014-05-20 | MAXXAM INC | MXM | CRUIKSHANK ROBERT J (Director) | 600 | $24.9 | 600 (Direct) | View |
| 2004-05-11 Option Award |
2004-05-12 3:26 pm | N/A 2014-05-11 | ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 7,500 | $8.72 | 7,500 (Direct) |
View |
| 2004-05-05 Exercise | 2004-05-07 6:04 pm |
N/A 2004-05-21 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | CRUIKSHANK ROBERT J (Director) | 2,203 | $4.54 | 0 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 09 Jan 2009 00:42:25 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |